BiotechTube
Home/Lexaria Bioscience/Chris Bunka
CB

Chris Bunka

Chief Executive Officer & Chairman

Lexaria Bioscience

Therapeutic Areas

CardiovascularNeurologyMetabolic DiseaseVirologySmoking Cessation

Lexaria Bioscience Pipeline

DrugIndicationPhase
DehydraTECH-CBDHypertensionHuman Clinical
DehydraTECH-NicotineSmoking CessationHuman Clinical
DehydraTECH for AntiviralsViral InfectionsPreclinical
DehydraTECH-sildenafilErectile DysfunctionHuman Clinical
DehydraTECH for GLP-1Diabetes/ObesityResearch

Leadership Team at Lexaria Bioscience

JD
John Docherty
President & Director
GD
Gregory Downey
Chief Financial Officer
View full Lexaria Bioscience profile